Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 12
Submit an article Journal homepage
68
Views
26
CrossRef citations to date
0
Altmetric
Research Article

Infliximab for the Treatment of Severe Steroid Refractory Acute Graft-versus-host Disease in Three Patients after Allogeneic Hematopoietic Transplantation

Takahisa Yamane Department of Clinical Hematology and Clinical Diagnostics, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8586, Japan
,
Ryousuke Yamamura Department of Clinical Hematology and Clinical Diagnostics, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8586, Japan
,
Yasutaka Aoyama Department of Clinical Hematology and Clinical Diagnostics, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8586, Japan
,
Hirohisa Nakamae Department of Clinical Hematology and Clinical Diagnostics, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8586, Japan
,
Taro Hasegawa Department of Clinical Hematology and Clinical Diagnostics, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8586, Japan
,
Chikahiko Sakamoto Department of Clinical Hematology and Clinical Diagnostics, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8586, Japan
,
Hisako Shibata Department of Clinical Hematology and Clinical Diagnostics, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8586, Japan
,
Yoshiki Terada Department of Clinical Hematology and Clinical Diagnostics, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8586, Japan
,
Genju Koh Department of Clinical Hematology and Clinical Diagnostics, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8586, Japan
&
Mayasuki Hino Department of Clinical Hematology and Clinical Diagnostics, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8586, Japan
 show all
Pages 2095-2097 | Published online: 05 Aug 2011

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

T Schroeder, R Haas & G Kobbe. (2010) Treatment of graft-versus-host disease with monoclonal antibodies and related fusion proteins. Expert Review of Hematology 3:5, pages 633-651.
Read now

Articles from other publishers (25)

Semra Bulbuloglu, Hüseyin Gunes & Serdar Saritas. (2022) The effect of long-term immunosuppressive therapy on gastrointestinal symptoms after kidney transplantation. Transplant Immunology 70, pages 101515.
Crossref
Marietta Nygaard, Niels Smedegaard Andersen, Claus Ernst Moser, Gitte Olesen, Ida Marie Schjødt, Carsten Heilmann & Henrik Sengeløv. (2018) Evaluation of infliximab as second-line treatment of acute graft versus host disease -validating response on day 7 and 28 as predictors of survival. Bone Marrow Transplantation 53:7, pages 844-851.
Crossref
Fevzi F. Yalniz, Mehrdad Hefazi, Kristen McCullough, Mark R. Litzow, William J. Hogan, Robert Wolf, Hassan Alkhateeb, Ankit Kansagra, Moussab Damlaj & Mrinal M. Patnaik. (2017) Safety and Efficacy of Infliximab Therapy in the Setting of Steroid-Refractory Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation 23:9, pages 1478-1484.
Crossref
Amira Elbendary & Roselyn Kellen. (2017) Off-Label uses of Biologic Agents Approved for Psoriasis and Psoriatic Arthritis for Dermatological Conditions: Part II. Journal of Psoriasis and Psoriatic Arthritis 2:2, pages 65-72.
Crossref
Koichi Miyamura. (2016) Insurance approval of mesenchymal stem cell for acute GVHD in Japan: need of follow up for some remaining concerns. International Journal of Hematology 103:2, pages 155-164.
Crossref
Makoto Murata. (2015) Prophylactic and therapeutic treatment of graft-versus-host disease in Japan. International Journal of Hematology 101:5, pages 467-486.
Crossref
Daniel Wolff, Francis Ayuk, Ahmet Elmaagacli, Hartmut Bertz, Anita Lawitschka, Michael Schleuning, Ralf-Georg Meyer, Armin Gerbitz, Inken Hilgendorf, Gerhard C. Hildebrandt, Matthias Edinger, Stephan Klein, Jörg Halter, Sabine Mousset, Ernst Holler & Hildegard T. Greinix. (2013) Current Practice in Diagnosis and Treatment of Acute Graft-versus-Host Disease: Results from a Survey among German-Austrian-Swiss Hematopoietic Stem Cell Transplant Centers. Biology of Blood and Marrow Transplantation 19:5, pages 767-776.
Crossref
Jun Yang, Daniel Ka Leung Cheuk, Shau Yin Ha, Alan Kwok Shing Chiang, Tsz Leung Lee, Marco Hok Kung Ho & Godfrey Chi Fung Chan. (2012) Infliximab for steroid refractory or dependent gastrointestinal acute graft‐versus‐host disease in children after allogeneic hematopoietic stem cell transplantation. Pediatric Transplantation 16:7, pages 771-778.
Crossref
Batya B. Davidovici & Ronni Wolf. 2011. Emergency Dermatology. Emergency Dermatology 34 49 .
Joseph Pidala & Claudio Anasetti. (2010) Glucocorticoid-Refractory Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation 16:11, pages 1504-1518.
Crossref
E. J. Bow. (2009) Invasive Fungal Infection in Haematopoietic Stem Cell Transplant Recipients: Epidemiology from the Transplant Physician’s Viewpoint. Mycopathologia 168:6, pages 283-297.
Crossref
Joseph Pidala, Jongphil Kim, Teresa Field, Ali McBride, Mohamed Kharfan-Dabaja, Janelle Perkins, Hugo Fernandez, Lia Perez, Ernesto Ayala & Claudio Anasetti. (2009) Infliximab for Managing Steroid-Refractory Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation 15:9, pages 1116-1121.
Crossref
Mehdi Hamadani, Craig C. Hofmeister, Buffy Jansak, Gary Phillips, Patrick Elder, William Blum, Sam Penza, Thomas S. Lin, Rebecca Klisovic, Guido Marcucci, Sherif S. Farag & Steven M. Devine. (2008) Addition of Infliximab to Standard Acute Graft-versus-Host Disease Prophylaxis following Allogeneic Peripheral Blood Cell Transplantation. Biology of Blood and Marrow Transplantation 14:7, pages 783-789.
Crossref
Vincent T. Ho & Corey Cutler. (2008) Current and novel therapies in acute GVHD. Best Practice & Research Clinical Haematology 21:2, pages 223-237.
Crossref
Sotirios Tsiodras, George Samonis, Dimitrios T. Boumpas & Dimitrios P. Kontoyiannis. (2008) Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy. Mayo Clinic Proceedings 83:2, pages 181-194.
Crossref
Sotirios Tsiodras, George Samonis, Dimitrios T. Boumpas & Dimitrios P. Kontoyiannis. (2008) Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy. Mayo Clinic Proceedings 83:2, pages 181-194.
Crossref
B. Díaz-Ley, G. Guhl & J. Fernández-Herrera. (2007) Uso de fármacos biológicos en dermatosis fuera de la indicación aprobada. Primera parte: infliximab y adalimumab. Actas Dermo-Sifiliográficas 98:10, pages 657-678.
Crossref
B S Sleight, K W Chan, T M Braun, A Serrano & A L Gilman. (2007) Infliximab for GVHD therapy in children. Bone Marrow Transplantation 40:5, pages 473-480.
Crossref
Vilmarie Rodriguez, Peter M. Anderson, Barbara A. Trotz, Carola A.S. Arndt, Julia A. Allen & Shakila P. Khan. (2007) Use of infliximab‐daclizumab combination for the treatment of acute and chronic graft‐versus‐host disease of the liver and gut. Pediatric Blood & Cancer 49:2, pages 212-215.
Crossref
Julia E. Graves, Kara Nunley & Michael P. Heffernan. (2007) Off-label uses of biologics in dermatology: Rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (Part 2 of 2). Journal of the American Academy of Dermatology 56:1, pages e55-e79.
Crossref
B. Díaz-Ley, G. Guhl & J. Fernández-Herrera. (2007) Off-Label Use of Biologic Agents in the Treatment of Dermatosis, Part 1: Infliximab and Adalimumab. Actas Dermo-Sifiliográficas (English Edition) 98:10, pages 657-678.
Crossref
Mary Jo. J. Kerns, Julia E. Graves, David I. Smith & Michael P. Heffernan. (2006) Off-Label Uses of Biologic Agents in Dermatology: A 2006 Update. Seminars in Cutaneous Medicine and Surgery 25:4, pages 226-240.
Crossref
G A Kennedy, J Butler, R Western, J Morton, S Durrant & G R Hill. (2006) Combination antithymocyte globulin and soluble TNFα inhibitor (etanercept) +/− mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease. Bone Marrow Transplantation 37:12, pages 1143-1147.
Crossref
D Wolff, V Roessler, B Steiner, S Wilhelm, V Weirich, J Brenmoehl, M Leithaeuser, N Hofmeister, C Junghanss, J Casper, G Hartung, E Holler & M Freund. (2005) Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept. Bone Marrow Transplantation 35:10, pages 1003-1010.
Crossref
Javier Bola??os-Meade & Georgia B Vogelsang. (2005) Novel strategies for steroid-refractory acute graft-versus-host disease. Current Opinion in Hematology 12:1, pages 40-44.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.